Senseonics Holdings, Inc. SENS recently scored a meaningful regulatory win in Europe, receiving CE Mark approval for its ...

Eversense 365 is the world’s first and only one year CGM, which was approved by the United States (US) Food and Drug Administration in September of 2024 and launched across the country in October of ...

[28 January 2026]: Roche Diagnostics Middle East presented a landmark launch event revealing Accu-Chek SmartGuide, a ...

Apple Watch now supports glucose monitoring via CGMs like Dexcom G7, while Apple continues long-term work on non-invasive blood sugar tracking.

Detailed price information for Senseonics Holdings Inc (SENS-Q) from The Globe and Mail including charting and trades.

Editor's Note: This story was edited on June 27, 2024, to include data from a second study on the same topic also presented at the American Diabetes Association Scientific Sessions. ORLANDO, Fla. — ...

DUBLIN--(BUSINESS WIRE)--The "Global Continuous Glucose Monitoring Market Report by Component, End-User, Regions and Company Analysis 2024-2032" report has been added to ResearchAndMarkets.com's ...

Experts discuss the clinical and practical factors that guide decision-making when recommending continuous glucose monitoring (CGM) vs traditional glucose monitoring for patients with type 2 diabetes.

The initiative aims to move beyond single-parameter glucose tracking by integrating key cardio-metabolic biomarkers directly ...

Please provide your email address to receive an email when new articles are posted on . “Our finding of nonadherence or no glucose monitoring suggests that a large number of beneficiaries were ...